Putting this into practice
Winners Consulting helps organizations turn this concept into workable policies, processes and audit readiness.
Need help with compliance implementation?
Request Free AssessmentThe Hatch-Waxman Act is a U.S. law balancing brand-name drug innovation with generic competition. It established the Abbreviated New Drug Application (ANDA) pathway, creating significant patent litigation risks and market exclusivity opportunities for pharmaceutical firms under the U.S. Code.
Curated by Winners Consulting Services Co., Ltd.
Winners Consulting helps organizations turn this concept into workable policies, processes and audit readiness.
Need help with compliance implementation?
Request Free Assessment